Home Supplements How We Rate Blog
Serenoa repens

Saw Palmetto

Research reviewed: up until 05/2023

Saw Palmetto (Serenoa repens) is a dietary supplement with 2 published peer-reviewed studies involving 100 participants, researched for Hair loss.

2
Studies
100
Participants
2012–2020
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Moderate Evidence

Hair loss

Moderate
2 studies 0 of 2 positive 100 participants

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

0/2
Randomised
0/2
Double-Blind
0/2
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2020)
0
Study 1 (2012)
100

Research Timeline

When the studies were published

1
2012
1
2020

All Studies

Detailed breakdown of each trial. Click to expand.

Hair loss

1

To describe the effects of Saw Palmetto extract on hair loss conditions and its associated side effects. Intervention under study: Oral and topical supplements containing 100-320 mg/day Saw Palmetto Studies Reviewed: 5 randomised controlled trials, 3 prospective cohort studies, and 1 case report

2020
Human Study Mixed

Study Type

Systematic review

Purpose

To describe the effects of Saw Palmetto extract on hair loss conditions and its associated side effects. Intervention under study: Oral and topical supplements containing 100-320 mg/day Saw Palmetto Studies Reviewed: 5 randomised controlled trials, 3 prospective cohort studies, and 1 case report

Results

The systematic review found associations between saw palmetto supplements and positive effects on patients with androgenetic alopecia (male pattern hair loss) and telogen effluvium (temporary hair loss that usually happens after stress, a shock, or a traumatic event), such as improvements in hair quality by 60%, hair density, and hair count by 3.4 to 27%.

Read full study
1

To compare the effects of Serenoa repens (saw palmetto) with finasteride on treating male androgenetic alopecia

2012 100 participants 2 years 320 mg/day of saw palmetto or 1 mg/day finasteride per day
Human Study Mixed

Study Type

Clinical trial (Uncontrolled)

Purpose

To compare the effects of Serenoa repens (saw palmetto) with finasteride on treating male androgenetic alopecia

Dose

320 mg/day of saw palmetto or 1 mg/day finasteride per day

Participants

100 men aged 20 to 40 years

Duration

2 years

Results

The study found an association between that 320 mg/day of saw palmetto and an increase in crown hair growth in 38% of patients. 68% of those treated with finasteride noted an improvement.

Read full study

Frequently Asked Questions

Common questions about Saw Palmetto research

What does the research say about Saw Palmetto?

There are currently 2 peer-reviewed studies on Saw Palmetto (Serenoa repens), involving 100 total participants. Research covers Hair loss. The overall evidence strength is rated as Moderate.

How strong is the evidence for Saw Palmetto?

The evidence is currently rated as "Moderate Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (2 human studies), and reported outcomes.

What health goals has Saw Palmetto been studied for?

Saw Palmetto has been researched for: Hair loss. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Saw Palmetto based on human trials?

Yes, 2 out of 2 studies are human trials. Human trials carry more weight in our evidence scoring system.